{"id":629524,"date":"2024-08-20T13:50:54","date_gmt":"2024-08-20T17:50:54","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=629524"},"modified":"2024-10-25T09:47:01","modified_gmt":"2024-10-25T13:47:01","slug":"fiasp-flextouch-without-insurance","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/fiasp-flextouch-without-insurance\/","title":{"rendered":"How much is Fiasp Flextouch without insurance?"},"content":{"rendered":"

Fiasp Flextouch<\/span><\/a> is a rapid- or fast-acting insulin pen containing insulin aspart. It is <\/span>approved by the Food and Drug Administration (FDA)<\/span><\/a> to help manage blood sugar levels in individuals with diabetes mellitus. It is typically injected into the thigh, arm, or abdomen right before a meal or within 20 minutes after eating. Fiasp Flextouch is a prefilled pen that offers users a discreet and convenient way to administer insulin aspart.<\/span><\/p>\n

Without insurance, the cost of Fiasp Flextouch for five pens can be over $700. Many people may be unable to afford this insulin product without insurance. However, various ways to lower the price, including discount cards and savings offers, may exist.<\/span><\/p>\n

Is there a generic for Fiasp Flextouch?<\/span><\/h2>\n

Currently, no generic version of Fiasp FlexTouch is available. Fiasp, which is manufactured by Novo Nordisk, is unique due to its incorporation of <\/span>niacinamide<\/span><\/a> (vitamin B3). This addition helps increase the speed of insulin absorption after injection.<\/span><\/p>\n

The earliest the <\/span>patent for the brand name may expire is 2026<\/span><\/a>, after which a generic version may be made available. <\/span>Novolog<\/span><\/a> is a rapid-acting insulin that is similar to Fiasp and contains insulin aspart. It doesn’t contain niacinamide, but otherwise provides comparable effects. Still, Novolog is not an interchangeable generic version of Fiasp Flextouch. <\/span><\/p>\n

Is Fiasp Flextouch covered by insurance?<\/span><\/h2>\n

Fiasp Flextouch may be covered by various health insurance plans, including employer-sponsored insurance and private insurance. People with insurance may find it helpful to talk to their healthcare provider or pharmacist about their specific plan’s coverage. Medicare typically covers Fiasp Flextouch under Medicare Part D or Medicare Advantage plans. However, coverage details, such as copay amounts, can differ greatly.<\/span><\/p>\n

Before covering Fiasp Flextouch, some insurance plans might require <\/span>prior authorization<\/span><\/a>. This means that your healthcare provider will need to submit a request to the insurance company to confirm that the medication is medically necessary for your condition. The process can vary between plans, and it’s important for patients to ensure that this step is completed to avoid unexpected out-of-pocket costs.<\/span><\/p>\n

When it comes to costs, you may encounter different types of expenses, such as copays, coinsurance, and deductibles. A copay is a fixed amount you pay when you pick up your medication at the pharmacy, while coinsurance is a percentage of the medication cost you are responsible for after meeting your deductible. Deductibles are the total amount you need to pay out-of-pocket before your insurance starts to cover the costs.<\/span><\/p>\n

How much does Fiasp Flextouch cost without insurance?<\/span><\/h2>\n

Fiasp Flextouch pens can vary when not covered by insurance. As of the time of publication, the average retail price for a pack of five pens is around $765. Each pen contains 3 milliliters (mL) of insulin with a concentration of 100 units\/mL, totaling 300 units per pen.<\/span><\/p>\n

To understand the costs better, here’s a breakdown:<\/span><\/p>\n